Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario W Kramer

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Oncology Letters|January 27, 2017
Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapyChristoph A von Klot, Markus A Kuczyk, Alena Boeker, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|January 23, 2014
Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancerMario W Kramer, Islam F Abdelkawi, Mathias Wolters, et al.
Biomarkers in Medicine|April 9, 2011
Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancerSandra Waalkes, Hendrik Eggers, Hanna Blasig, et al.
BMC Clinical Pathology|April 9, 2014
Galectin-1 and Galectin-3 mRNA expression in renal cell carcinomaChristoph-A von Klot, Mario W Kramer, Inga Peters, et al.
Advances in Therapy|September 21, 2018
Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)André P Nicklas, Mario W Kramer, Jürgen Serth, et al.
Urologia Internationalis|July 27, 2023
The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder TumoursJulian P Struck, Tomasz Ozimek, Maike Schnoor, et al.
Urologic Oncology|February 4, 2018
Diarrhea and flatulence are major bowel disorders after radical cystectomy: Results from a cross-sectional study in bladder cancer patientsMarie C Hupe, Winfried Vahlensieck, Tomasz Ozimek, et al.
Oncology Reports|February 20, 2014
GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinomaInga Peters, Kai Gebauer, Natalia Dubrowinskaja, et al.
Frontiers in Oncology|June 13, 2020
Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy-Real-World Clinical Impressions and Comparative Review of the LiteratureChristian Fuhrmann, Julian P Struck, Philipp Ivanyi, et al.
BMC Cancer|February 23, 2020
Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancerMarie C Hupe, Lukas Dormayer, Tomasz Ozimek, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Oncology Letters|January 27, 2017
Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapyChristoph A von Klot, Markus A Kuczyk, Alena Boeker, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|January 23, 2014
Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancerMario W Kramer, Islam F Abdelkawi, Mathias Wolters, et al.
Biomarkers in Medicine|April 9, 2011
Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancerSandra Waalkes, Hendrik Eggers, Hanna Blasig, et al.
BMC Clinical Pathology|April 9, 2014
Galectin-1 and Galectin-3 mRNA expression in renal cell carcinomaChristoph-A von Klot, Mario W Kramer, Inga Peters, et al.
Advances in Therapy|September 21, 2018
Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)André P Nicklas, Mario W Kramer, Jürgen Serth, et al.
Urologia Internationalis|July 27, 2023
The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder TumoursJulian P Struck, Tomasz Ozimek, Maike Schnoor, et al.
Urologic Oncology|February 4, 2018
Diarrhea and flatulence are major bowel disorders after radical cystectomy: Results from a cross-sectional study in bladder cancer patientsMarie C Hupe, Winfried Vahlensieck, Tomasz Ozimek, et al.
Oncology Reports|February 20, 2014
GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinomaInga Peters, Kai Gebauer, Natalia Dubrowinskaja, et al.
Frontiers in Oncology|June 13, 2020
Checkpoint Inhibition for Metastatic Urothelial Carcinoma After Chemotherapy-Real-World Clinical Impressions and Comparative Review of the LiteratureChristian Fuhrmann, Julian P Struck, Philipp Ivanyi, et al.
BMC Cancer|February 23, 2020
Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancerMarie C Hupe, Lukas Dormayer, Tomasz Ozimek, et al.
Pageof 8